Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Pakistan Journal of Pharmaceutical Sciences is Scopus-indexed (Q3, CiteScore 1.1), WoS SCIE, DOAJ. Published by Pakistan Journal of Pharmaceutical Sciences.
Checked against the index lists dated .
ISSN 1011-601XVerify ISSN ↗
Publisher: Pakistan Journal of Pharmaceutical Sciences
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 138 / 191 | 28th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present (also 1995), best quartile Q3, CiteScore 1.1.
Pakistan Journal of Pharmaceutical Sciences is Q3 in Pharmaceutical Science (rank 138 of 191), by CiteScore 2025.
Pakistan Journal of Pharmaceutical Sciences is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.1, which places it in quartile Q3 at the 28th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.201, quartile Q3, with an H-index of 53.
Pakistan Journal of Pharmaceutical Sciences is published by Pakistan Journal of Pharmaceutical Sciences. Its ISSN is 1011-601X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Pakistan Journal of Pharmaceutical Sciences has an h-index of 18 and a 2-year mean of 0.12 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q3. On 2-year citations it ranks #156 of 177 Scopus journals in Pharmaceutical Science.
Pakistan Journal of Pharmaceutical Sciences published 280 papers in 2025; its busiest recent year was 2019 with 440. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 80 research articles (2026), authors are most often from China (81.3%), Pakistan (12.5%) and Türkiye (3.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 3 retracted papers are recorded (0.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.